Company news

Lumos Diagnostics Holdings Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Reinstatement to Quotation

July 16, 2025

Lumos Signs Pivotal US FebriDx Agreement

July 16, 2025

Suspension from Quotation

July 14, 2025

Pause in Trading

July 11, 2025

Lumos Reaches FebriDx CLIA Waiver Study Enrolment Milestone

June 18, 2025

Lumos Reaches Recruitment Milestone in FebriDx Study

June 1, 2025

Lumos Secures Sixth US Medicare Reimbursement for FebriDx

May 26, 2025

Lumos Secures Fifth US Medicare Reimbursement for FebriDx

May 19, 2025

Lumos Advances FebriDx Sales with iMedical Purchase Order

May 13, 2025

Lumos Secures Further US Medicare Reimbursement for FebriDx

April 23, 2025

Lumos Secures Key US Reimbursement Milestones for FebriDx

April 17, 2025

Hologic Development Agreement Expanded Scope of Works

March 2, 2025

Commencement of FebriDx CLIA Waiver Study

December 19, 2024

Lumos receives CPT PLA Code for FebriDX in the US

December 4, 2024

Lumos Successfully Completes Retail Entitlement Offer

October 7, 2024

Lumos and BARDA Partner to Support FebriDx CLIA Waiver Study

October 2, 2024

Lumos Awarded National Contract with MediGroup for FebriDx

September 25, 2024

Lumos Achieves First Phase 2 Milestone in Hologic Agreement

September 20, 2024

Lumos Appoints Thermo Fisher Scientific as US Distributor

September 15, 2024

Retail Entitlement Offer Booklet

September 10, 2024

Lumos Successfully Completes Institutional Entitlement Offer

September 5, 2024

Lumos Announces $10m Equity Raising and Welcomes Tenmile

September 4, 2024

Lumos Announces Intention to Undertake Entitlement Offer

September 3, 2024

FY24 Full Year Results Announcement

August 26, 2024

FY24 Appendix 4E

August 26, 2024

Lumos and BDI Progress New Point of Care Test

August 25, 2024

Lumos Expands Henry Schein FebriDx Distribution Partnership

July 8, 2024

Lumos Expands Distribution for FebriDx in AUS and NZ

July 3, 2024

Lumos Receives Second US$5 million Hologic IP Payment

June 3, 2024

Lumos Achieves Key Phase 1 Milestone in Hologic Agreement

May 5, 2024

Half Year Results Investor Presentation

February 27, 2024

Lumos Appoints Henry Schein as US Distributor for FebriDx

February 11, 2024

Lumos Signs Major Development and IP Agreements with Hologic

January 10, 2024

Commercial Operations Update Webinar Presentation

December 5, 2023

LDX Raises A$2.65 Million in Successful Placement

October 29, 2023

FDA Grants EUA for ViraDx

September 10, 2023

FY23 Full Year Results Investor Presentation

August 29, 2023

FY23 Full Year Results Announcement

August 29, 2023

FY23 Appendix 4E

August 29, 2023

Henry Schein Expands Distribution Partnership for FebriDx

August 15, 2023

Core Camera Reader Patent Granted in Europe and Japan

August 15, 2023

Completion of Early Redemption of Convertible Notes

August 10, 2023

Lumos Receives Research & Development Tax Rebate

August 10, 2023

Capital Raise Result and Issue of Early Redemption Notices

August 2, 2023

Lumos Secures Feasibility Project with BDI

July 26, 2023

Henry Schein Expands Distribution Partnership For FebriDx

July 17, 2023

Lumos completes $4.75m Placement and launches SPP

July 9, 2023

Lumos Receives US FDA Clearance for FebriDx

July 2, 2023

Lumos signs three new agreements with Hologic

March 15, 2023

Lumos Diagnostics FY23 First Half Year Results

February 26, 2023

← Newer news releases · Older news releases →

Calls

Decks

The 5 newest of 35 decks. Every deck is listed under its year.